 WOODCLIFF LAKE, N.J.--BUSINESS WIRE--Eagle Pharmaceuticals, Inc. Eagle or the Company Nasdaq: EGRX today announced that the Company will release its 2020 fourth quarter and full year financial results on Tuesday, March 2, 2021, before the market opens. Scott Tarriff, Chief Executive Officer, Brian Cahill, Chief Financial Officer, senior members of Eagles executive leadership team, and other distinguished external speakers will host a 90- minute conference call as follows: Date Tuesda 